Literature DB >> 21762911

Bone graft substitutes in active or suspected infection. Contra-indicated or not?

Jan Geurts1, J J Chris Arts, G H I M Walenkamp.   

Abstract

Treatment of infection in clinical orthopaedic and trauma care is a time consuming and costly endeavour. More than once, it will lead to extraction of implant material and additional surgical interventions. Currently, debridement, implantation of PMMA beads impregnated with antibiotics most often with implant exchange are the gold standard for deep infection treatment. Recently bone graft substitute materials such as calcium phosphate, collagen fleeces and bioglasses have appeared for specific use in infection treatment. Although these materials show great potential, their supporting level of evidence is still limited. This review paper provides an overview of current understanding and therapies for infection treatment and provides concepts for the use of new developed biomaterials in infection treatment. Furthermore, the benefits and risks of using biomaterials in infection treatment are discussed and the level of evidence of a number of new materials is presented.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762911     DOI: 10.1016/j.injury.2011.06.189

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  16 in total

1.  Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis.

Authors:  J McAndrew; C Efrimescu; E Sheehan; D Niall
Journal:  Ir J Med Sci       Date:  2013-01-05       Impact factor: 1.568

2.  Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience.

Authors:  Eva Steinhausen; Rolf Lefering; Martin Glombitza; Nikolaus Brinkmann; Carsten Vogel; Bastian Mester; Marcel Dudda
Journal:  J Bone Jt Infect       Date:  2021-01-12

3.  (18)F-FDG microPET imaging differentiates between septic and aseptic wound healing after orthopedic implant placement: a longitudinal study of an implant osteomyelitis in the rabbit tibia.

Authors:  Jim C E Odekerken; Boudewijn T Brans; Tim J M Welting; Geert H I M Walenkamp
Journal:  Acta Orthop       Date:  2014-03-27       Impact factor: 3.717

Review 4.  Clinical Application of Antimicrobial Bone Graft Substitute in Osteomyelitis Treatment: A Systematic Review of Different Bone Graft Substitutes Available in Clinical Treatment of Osteomyelitis.

Authors:  T A G van Vugt; J Geurts; J J Arts
Journal:  Biomed Res Int       Date:  2016-01-21       Impact factor: 3.411

5.  Calcium-Based, Antibiotic-Loaded Bone Substitute as an Implant Coating: A Pilot Clinical Study.

Authors:  N Logoluso; L Drago; E Gallazzi; D A George; I Morelli; C L Romanò
Journal:  J Bone Jt Infect       Date:  2016-10-01

6.  Vancomycin-Loaded Collagen/Hydroxyapatite Layers Electrospun on 3D Printed Titanium Implants Prevent Bone Destruction Associated with S. epidermidis Infection and Enhance Osseointegration.

Authors:  Tomáš Suchý; Lucie Vištejnová; Monika Šupová; Pavel Klein; Martin Bartoš; Yaroslav Kolinko; Tereza Blassová; Zbyněk Tonar; Marek Pokorný; Zbyněk Sucharda; Margit Žaloudková; František Denk; Rastislav Ballay; Štefan Juhás; Jana Juhásová; Eva Klapková; Lukáš Horný; Radek Sedláček; Tomáš Grus; Zdeněk Čejka; Zdeněk Čejka; Kateřina Chudějová; Jaroslav Hrabák
Journal:  Biomedicines       Date:  2021-05-10

7.  Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study.

Authors:  Lorenzo Drago; Delia Romanò; Elena De Vecchi; Christian Vassena; Nicola Logoluso; Roberto Mattina; Carlo Luca Romanò
Journal:  BMC Infect Dis       Date:  2013-12-10       Impact factor: 3.090

Review 8.  Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review.

Authors:  N A P van Gestel; J Geurts; D J W Hulsen; B van Rietbergen; S Hofmann; J J Arts
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

9.  Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: In vitro and clinical release studies.

Authors:  M Stravinskas; P Horstmann; J Ferguson; W Hettwer; M Nilsson; S Tarasevicius; M M Petersen; M A McNally; L Lidgren
Journal:  Bone Joint Res       Date:  2016-09       Impact factor: 5.853

10.  ELISA-based detection of gentamicin and vancomycin in protein-containing samples.

Authors:  Jim C E Odekerken; Dorien M W Logister; Loubna Assabre; Jacobus J C Arts; Geert H I M Walenkamp; Tim J M Welting
Journal:  Springerplus       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.